Literature DB >> 15392831

The protease and antiprotease of plasmas of patients with cancer and other diseases.

G H L DILLARD, A CHANUTIN.   

Abstract

Entities:  

Keywords:  BLOOD; CANCER

Mesh：

Substances：

Year:  1949        PMID： 15392831

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.

Authors:  N ENDE; J V AUDITORE
Journal:  Ann Surg       Date:  1963-07       Impact factor: 12.969

2.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject.

Authors:  M M GUEST
Journal:  J Clin Invest       Date:  1954-11       Impact factor: 14.808

4.  The twenty-four excretion of trypsin and trypsinogen in the urine.

Authors:  F Romero; F W Pairent; H E Appert; J M Howard
Journal:  Ann Surg       Date:  1972-08       Impact factor: 12.969

5.  Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection.

Authors:  Matthew J Kesic; Megan Meyer; Rebecca Bauer; Ilona Jaspers
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

6.  Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum.

Authors:  P S NORMAN
Journal:  J Exp Med       Date:  1957-09-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.